01:39:02 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-05-10 Ordinarie utdelning REDS 0.00 SEK
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-08 Årsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-29 Kvartalsrapport 2023-Q2
2023-05-10 Ordinarie utdelning REDS 0.00 SEK
2023-05-09 Kvartalsrapport 2023-Q1
2023-05-09 Årsstämma 2023
2023-02-27 Bokslutskommuniké 2022
2022-11-09 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-05-03 Ordinarie utdelning REDS 0.00 SEK
2022-05-02 Årsstämma 2022
2022-05-02 Kvartalsrapport 2022-Q1
2022-02-28 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-05-12 Årsstämma 2021
2021-05-05 Ordinarie utdelning REDS 0.00 SEK
2021-05-03 Kvartalsrapport 2021-Q1
2021-04-19 Extra Bolagsstämma 2021
2021-02-28 Bokslutskommuniké 2020
2020-12-18 Extra Bolagsstämma 2020
2020-11-09 Kvartalsrapport 2020-Q3
2020-08-24 Kvartalsrapport 2020-Q2
2020-06-23 Ordinarie utdelning REDS 0.00 SEK
2020-06-22 Årsstämma 2020
2020-05-04 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2019-11-18 Kvartalsrapport 2019-Q3
2019-08-26 Kvartalsrapport 2019-Q2
2019-05-07 Ordinarie utdelning REDS 0.00 SEK
2019-05-06 Årsstämma 2019
2019-05-06 Kvartalsrapport 2019-Q1
2019-02-26 Bokslutskommuniké 2018
2018-08-27 Kvartalsrapport 2018-Q2
2018-05-08 Ordinarie utdelning REDS 0.00 SEK
2018-05-07 Årsstämma 2018
2018-02-27 Bokslutskommuniké 2017
2017-09-25 Extra Bolagsstämma 2017
2017-08-28 Kvartalsrapport 2017-Q2
2017-04-06 Ordinarie utdelning REDS 0.00 SEK
2017-04-05 Årsstämma 2017
2017-02-22 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-09 Årsstämma 2016
2016-05-09 Kvartalsrapport 2016-Q1
2016-02-23 Ordinarie utdelning REDS 0.00 SEK
2016-02-22 Bokslutskommuniké 2015
2015-11-27 Kvartalsrapport 2015-Q3

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Redsense Medical är ett medicinteknikbolag som är specialiserat inom utvecklingen av blodläckage-alarm. Bolagets produkt fungerar som en sensor baserad på fiberteknik som snabbare skall upptäcka blodförlust, samt larma och rapportera till olika larmenheter. Utöver huvudverksamheten erbjuds träning och utbildning inom affärsområdet. Bolaget grundades år 2006 och har sitt huvudkontor i Halmstad.
2019-11-12 08:00:00

Redsense Medical has signed an agreement with Ann-Marie Eriksson, who will be the Company's new Chief Technology Officer. When Ann-Marie joins the Company, she will be responsible for leading the R&D projects, a key task as the Company continues to develop its blood loss detection technology into a comprehensivesolution for smart wound care adapted to meet thedemands of the future. As the new CTO, she will also be responsible for managing the Company's regulatory work relating to quality systems, and for securing input to the Company's supply chain - a critical area, especially in view of the Company's expansion strategy to intensify and accelerate sales, with a particular focus on the rapidly growing US market, and to strengthen the supply chain to handle larger volumes.

"Redsense is a very exciting company, with great future prospects and a technology that may prove disruptive to the global wound care market. I look forward to doing my bit to turn that vision into reality, and I am very pleased to be able to contribute with my knowledge and experience in this important stage of the Company's journey," says Ann-Marie Eriksson.

Ann-Marie Eriksson holds a M.Sc. in Electrical Engineering with specialization in signal processing and telecommunications from the Chalmers Universityof Technology. Her most recent position was at the Halmstad branch of Etteplan Sweden AB, Swedish subsidiary of the international engineering group Etteplan, where she has lead the team successfully as Department Manager, Area Manager and Teamleader. She has solid experience of project management and quality systems management, with particular expertise in medical devices.

"We are positively thrilled to be able to welcome Ann-Marie to our team. Her significant experience from project management and regulatory frameworks in the context of medical devices is a valuable addition to Redsense. Ann-Marie provides the Company with unique new qualities, and she will play a pivotal role in our ongoing technology development and sales expansion," says Patrik Byhmer, CEO of Redsense Medical AB.